InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,678.91
(
0.61%
)
Post# of 252426
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

vinmantoo

Send PM Follow Ignore
Followers 30
Posts 4136
Boards Moderated 0
Alias Born 07/25/2007

vinmantoo

Re: DewDiligence post# 248589

Wednesday, 08/09/2023 9:27:02 PM

Wednesday, August 09, 2023 9:27:02 PM

Post# of 252426

AVIR modifies phase-3 protocol for COVID antiviral, bemnifosbuvir—(f/k/a AT-527):

https://ir.ateapharma.com/news-releases/news-release-details/atea-pharmaceuticals-reports-second-quarter-2023-financial



How can that be? Jake assured us that a phase 3 trial for anti-Covid drugs can't be run because Paxlovid is approved. Jake better rush in and tell AVIR and the FDA that a phase 3 trial can't be run.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up